Your browser doesn't support javascript.
loading
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles.
Brouwer, Philip J M; Antanasijevic, Aleksandar; de Gast, Marlon; Allen, Joel D; Bijl, Tom P L; Yasmeen, Anila; Ravichandran, Rashmi; Burger, Judith A; Ozorowski, Gabriel; Torres, Jonathan L; LaBranche, Celia; Montefiori, David C; Ringe, Rajesh P; van Gils, Marit J; Moore, John P; Klasse, Per Johan; Crispin, Max; King, Neil P; Ward, Andrew B; Sanders, Rogier W.
Afiliação
  • Brouwer PJM; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands.
  • Antanasijevic A; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • de Gast M; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands.
  • Allen JD; School of Biological Sciences, University of Southampton, Southampton, UK.
  • Bijl TPL; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands.
  • Yasmeen A; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, USA.
  • Ravichandran R; Department of Biochemistry, University of Washington, Seattle, WA, USA.
  • Burger JA; Institute for Protein Design, University of Washington, Seattle, WA, USA.
  • Ozorowski G; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands.
  • Torres JL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • LaBranche C; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
  • Ringe RP; Department of Surgery, Duke University Medical Center, Durham, NC, USA.
  • van Gils MJ; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, USA.
  • Moore JP; Institute of Microbial Technology, Chandigarh, India.
  • Klasse PJ; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands.
  • Crispin M; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, USA.
  • King NP; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, NY, USA.
  • Ward AB; School of Biological Sciences, University of Southampton, Southampton, UK.
  • Sanders RW; Department of Biochemistry, University of Washington, Seattle, WA, USA. neil@ipd.uw.edu.
NPJ Vaccines ; 6(1): 24, 2021 Feb 09.
Article em En | MEDLINE | ID: mdl-33563983

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article